Malignant peritoneal mesothelioma (MPM) is a rare disease with a wide clinical spectrum. It
arises from the peritoneal lining and commonly presents with diffuse, extensive spread …

Mesotheliomas are aggressive and lethal neoplasms arising from mesothelial cells lining
the pleura, peritoneum, tunica vaginalis testis and pericardium. Malignant peritoneal …

Purpose Pemetrexed in combination with cisplatin is approved for the treatment of pleural
mesothelioma and is active in malignant peritoneal mesothelioma (MPeM). Pemetrexed and …

Background: Mesothelioma of peritoneal origin has wider variation in treatment outcomes
than mesothelioma of pleural origin, likely because peritoneal mesothelioma comprises …

Mesothelioma often originates in the pleura and less frequently in the peritoneum. This
article describes a rare case of diffuse malignant peritoneal mesothelioma in a 54-year-old …

Report of a Case of Pericardial Mesothelioma with Liver Metastases Responding Well to
Pemetrexed and Platinum-Based Chemotherapy - ScienceDirect Skip to main contentSkip to …

Malignant mesotheliomas are aggressive neoplasms arising from mesothelial cells lining
the body cavities. Malignant peritoneal mesothelioma (MPM) account for about one-third of …

A 76‐year‐old woman presented with lower abdominal pain and nausea and was referred
to the gastroenterology department in our institution. Previous contrast‐enhanced computed …

Background: Malignant peritoneal mesothelioma (PM) is an extremely rare disease.
Pemetrexed and platinum have been used for advanced PM following malignant pleural …

Diffuse malignant peritoneal mesothelioma (DMPM) represents 90% of all peritoneal forms
of mesothelioma. It affects mainly patients 50-69 years old. In 50% of cases there is a history …